23andme Holding Co Stock Revenue

ME Stock  USD 3.61  0.06  1.69%   
23Andme Holding Co fundamentals help investors to digest information that contributes to 23Andme Holding's financial success or failures. It also enables traders to predict the movement of 23Andme Stock. The fundamental analysis module provides a way to measure 23Andme Holding's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 23Andme Holding stock.
Last ReportedProjected for Next Year
Total Revenue219.6 M237.5 M
At present, 23Andme Holding's Cost Of Revenue is projected to decrease significantly based on the last few years of reporting. The current year's Stock Based Compensation To Revenue is expected to grow to 0.57, whereas Research And Ddevelopement To Revenue is forecasted to decline to 0.53.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

23Andme Holding Co Company Revenue Analysis

23Andme Holding's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Revenue

 = 

Money Received

-

Discounts and Returns

More About Revenue | All Equity Analysis

Current 23Andme Holding Revenue

    
  219.64 M  
Most of 23Andme Holding's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 23Andme Holding Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Historical and Projected quarterly revenue of 23Andme

Projected quarterly revenue analysis of 23Andme Holding provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of 23Andme Holding match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in 23Andme Holding's stock price.

23Andme Revenue Driver Correlations

Understanding the fundamental principles of building solid financial models for 23Andme Holding is extremely important. It helps to project a fair market value of 23Andme Stock properly, considering its historical fundamentals such as Revenue. Since 23Andme Holding's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of 23Andme Holding's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of 23Andme Holding's interrelated accounts and indicators.

23Andme Revenue Historical Pattern

Today, most investors in 23Andme Holding Stock are looking for potential investment opportunities by analyzing not only static indicators but also various 23Andme Holding's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of 23Andme Holding revenue as a starting point in their analysis.
   23Andme Holding Revenue   
       Timeline  
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition

23Andme Current Deferred Revenue

Current Deferred Revenue

55.3 Million

At present, 23Andme Holding's Current Deferred Revenue is projected to decrease significantly based on the last few years of reporting.
Based on the latest financial disclosure, 23Andme Holding Co reported 219.64 M of revenue. This is 97.12% lower than that of the Biotechnology sector and 88.92% lower than that of the Health Care industry. The revenue for all United States stocks is 97.67% higher than that of the company.

23Andme Revenue Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 23Andme Holding's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 23Andme Holding could also be used in its relative valuation, which is a method of valuing 23Andme Holding by comparing valuation metrics of similar companies.
23Andme Holding is currently under evaluation in revenue category among its peers.

23Andme Holding ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, 23Andme Holding's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to 23Andme Holding's managers, analysts, and investors.
Environmental
Governance
Social

23Andme Holding Institutional Holders

Institutional Holdings refers to the ownership stake in 23Andme Holding that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of 23Andme Holding's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing 23Andme Holding's value.
Shares
Steel Partners Holdings Lp2024-06-30
2.1 M
Goldman Sachs Group Inc2024-06-30
1.9 M
Susquehanna International Group, Llp2024-06-30
1.8 M
Charles Schwab Investment Management Inc2024-06-30
1.8 M
State Street Corp2024-06-30
1.2 M
Amvescap Plc.2024-06-30
844.1 K
Fmr Inc2024-06-30
801.7 K
Morgan Stanley - Brokerage Accounts2024-06-30
787.2 K
Two Sigma Investments Llc2024-06-30
744.9 K
Newview Capital Partners I, Llc2024-06-30
19.5 M
Vanguard Group Inc2024-06-30
15.4 M

23Andme Fundamentals

About 23Andme Holding Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze 23Andme Holding Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 23Andme Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 23Andme Holding Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 23Andme Holding. If investors know 23Andme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 23Andme Holding listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(122.52)
Revenue Per Share
8.224
Quarterly Revenue Growth
(0.34)
Return On Assets
(0.26)
Return On Equity
(1.54)
The market value of 23Andme Holding is measured differently than its book value, which is the value of 23Andme that is recorded on the company's balance sheet. Investors also form their own opinion of 23Andme Holding's value that differs from its market value or its book value, called intrinsic value, which is 23Andme Holding's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 23Andme Holding's market value can be influenced by many factors that don't directly affect 23Andme Holding's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 23Andme Holding's value and its price as these two are different measures arrived at by different means. Investors typically determine if 23Andme Holding is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 23Andme Holding's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.